Close Menu

Note: This story has been updated with additional information from the company's earnings call.

NEW YORK – Roche on Thursday reported a 6 percent increase in sales of its diagnostics division for full-year 2020, driven primarily by its COVID-19 testing portfolio.

Overall, Roche reported CHF 58.32 billion ($64.66 billion) in revenues for the year, down 5 percent from CHF 61.47 in 2019, but up 1 percent at constant exchange rates, the firm said.

The pharmaceuticals division had CHF 44.53 billion in 2020 revenues, down 8 percent from CHF 48.52 billion in 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.